Amy L. Burroughs, Chief Executive Officer at Terns Pharmaceuticals, Inc. (TERN), bought 510 shares at $5.11 ($3K) on 2024-11-30, disclosed to the SEC on 2025-02-03.
Open-market purchase of $3k TERN by Chief Executive Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| TERN | SELL | 2026-01-16 | $5.1M | — | Filing → |
| TERN | SELL | 2026-01-06 | $5.4M | — | Filing → |
| TERN | BUY | 2025-06-25 | $180K | — | Filing → |